Congenital hyperinsulinism and panhypopituitarism: a rare combination.
Foram PatelGinger DarlingAhmed TorkyPublished in: Endocrinology, diabetes & metabolism case reports (2023)
FOXA2 has been shown to play an important role in the neuroectodermal and endodermal development. FOXA2 mutation may lead to the rare combination of hyperinsulinism and panhypopituitarism. Patients reported so far all responded well to diazoxide. Dysmorphology may be subtle, and liver functions should be monitored.